Jacobs Levy Equity Management, Inc Applied Genetic Technologies Corp Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.87 - $2.91 $651,807 - $1.01 Million
-348,560 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.01 - $4.12 $325,877 - $446,051
-108,265 Reduced 23.7%
348,560 $1.05 Million
Q2 2021

Aug 16, 2021
SELL
$3.62 - $5.23 $46,332 - $66,938
-12,799 Reduced 2.73%
456,825 $1.79 Million
Q1 2021

May 17, 2021
BUY
$3.94 - $8.19 $1.5 Million - $3.11 Million
379,716 Added 422.34%
469,624 $2.38 Million
Q4 2020

Feb 16, 2021
BUY
$3.99 - $5.7 $72,007 - $102,867
18,047 Added 25.11%
89,908 $368,000
Q3 2020

Nov 16, 2020
SELL
$4.38 - $6.43 $168,419 - $247,246
-38,452 Reduced 34.86%
71,861 $349,000
Q2 2020

Aug 17, 2020
SELL
$3.0 - $6.9 $125,094 - $287,716
-41,698 Reduced 27.43%
110,313 $611,000
Q1 2020

May 15, 2020
BUY
$2.36 - $9.86 $114,330 - $477,667
48,445 Added 46.78%
152,011 $499,000
Q4 2019

Feb 14, 2020
BUY
$2.69 - $4.92 $56,333 - $103,034
20,942 Added 25.35%
103,566 $468,000
Q3 2019

Nov 14, 2019
BUY
$2.59 - $4.16 $2,590 - $4,160
1,000 Added 1.23%
82,624 $344,000
Q2 2019

Aug 13, 2019
BUY
$3.6 - $4.78 $65,754 - $87,306
18,265 Added 28.83%
81,624 $309,000
Q4 2018

Feb 14, 2019
SELL
$2.28 - $7.15 $31,919 - $100,100
-14,000 Reduced 18.1%
63,359 $158,000
Q3 2018

Nov 14, 2018
BUY
$3.85 - $7.35 $28,875 - $55,125
7,500 Added 10.74%
77,359 $565,000
Q2 2018

Aug 14, 2018
BUY
$3.7 - $5.65 $258,478 - $394,703
69,859 New
69,859 $258,000
Q1 2018

May 15, 2018
SELL
$3.65 - $5.2 $51,100 - $72,800
-14,000 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$3.4 - $4.15 $47,600 - $58,100
14,000 New
14,000 $50,000
Q3 2017

Nov 14, 2017
SELL
$3.55 - $5.25 $74,195 - $109,725
-20,900 Closed
0 $0
Q2 2017

Nov 09, 2017
BUY
N/A
20,900
20,900 $107,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email